Riverview Medical Center LLC
Riverview Medical Center LLC was paid $5.23M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.
CARTHAGE, TN 37030
Next to other Neurology Physician providers in Tennessee
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,386 | $763K | |
| 2019 | 9,796 | $712K | |
| 2020 | 5,369 | $442K | |
| 2021 | 10,772 | $690K | |
| 2022 | 10,988 | $934K | |
| 2023 | 12,583 | $1.06M | |
| 2024incomplete | 6,184 | $628K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 7,987 | 6,974 | $1.80M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 7,915 | 7,103 | $1.48M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.4% | 3,059 | 2,307 | $494K |
| G0378 | Hospital observation service, per hour | 5.6% | 2,460 | 913 | $295K |
| 80053 | Comprehensive metabolic panel | 5.2% | 7,923 | 6,233 | $270K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 10,685 | 7,612 | $243K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 2,586 | 1,737 | $81K |
| 81001 | 1.5% | 4,907 | 4,128 | $78K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 535 | 307 | $52K |
| 84484 | <1% | 1,828 | 1,139 | $52K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,475 | 1,354 | $45K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,988 | 1,836 | $37K |
39 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,547 | $37K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 312 | $36K |
| 87430 | <1% | 761 | $31K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,213 | $26K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,094 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 939 | $18K |
| 87070 | <1% | 404 | $18K | |
| 81025 | <1% | 878 | $17K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 255 | $17K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 737 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 408 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 321 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 257 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,449 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 343 | $5K |
| 85610 | <1% | 613 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 114 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 157 | $3K |
| 0240U | <1% | 68 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 44 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 27 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 286 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 340 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 269 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 236 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 65 | $1K |
| 85730 | <1% | 133 | $1K | |
| 87081 | <1% | 34 | $981.20 | |
| 85379 | <1% | 52 | $901.89 | |
| 87641 | <1% | 32 | $694.24 | |
| 83690 | <1% | 30 | $605.87 | |
| 87040 | <1% | 61 | $525.42 | |
| 96376 | <1% | 76 | $464.05 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 31 | $417.85 |
| 85027 | <1% | 34 | $270.75 | |
| 87071 | <1% | 16 | $138.82 | |
| 83605 | <1% | 17 | $51.97 | |
| A9270 | Non-covered item or service | 0% | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.